Home › Enlarged Prostate (BPH) › NCT07789041

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

PuraStat for Aquablation Day Case (Use of PuraStat Following an Aquablation Procedure)

Who can join

Ages 18 and older · Men

Inclusion Criteria:

1. Subject must be undergoing Aquablation
2. Subject is willing to comply with protocol requirements

Exclusion Criteria:

1. Any significant medical condition which, in the attending physician's opinion, may interfere with the patient's optimal procedure
2. Known or suspected systemic or severe infection
3. Patient unable to give consent

About the study

Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

What is being tested

• PuraStat hydrogel and the syringe (device)

Sponsor: Endeavor Health · Participants: 50 · Started: Aug 12, 2025

Contact the study team

• Pooja Research Manager, MS MHA · Phone: 847-503-34280

Official record on ClinicalTrials.gov — NCT07789041

Locations in the U.S.

Conditions

• Enlarged Prostate (BPH)
• Urine and Urination

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.